Prosecution Insights
Last updated: November 20, 2026
Application No. 18/435,513

HIGHLY CROSSLINKED POLYMER PARTICULATE AND METHODS OF MANUFACTURING HIGHLY CROSSLINKED POLYMER PARTICULATE

Non-Final OA §103§112
Filed
Feb 07, 2024
Priority
Aug 16, 2019 — provisional 62/888,214 +4 more
Examiner
JOHNSTON, BRIEANN R
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Chevron Corporation
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
1m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
515 granted / 1037 resolved
-15.3% vs TC avg
Strong +33% interview lift
Without
With
+32.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
50 currently pending
Career history
1102
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
52.4%
+12.4% vs TC avg
§102
20.4%
-19.6% vs TC avg
§112
17.8%
-22.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1037 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 12-21 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The term “highly” in claims 12 and 19 is a relative term which renders the claim indefinite. The term “highly” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. In the instant specification, applicants disclose that the polyethylene chains may be highly crosslinked, and may have any suitable degree of crosslinking. This is not an explicit definition of the relative term “highly”; therefore, the scope of the term is indefinite. It is noted that since claims 13-18 and 20-21 ultimately or directly depend from claim 12, they are rejected along with claim 12 because they incorporate all of the limitations of claim 12, including those that are indefinite. In claim 18, applicants claim a Markush grouping of crosslinking agents as follows: “…wherein the crosslinking agent includes at least one of…” A list of specified alternatives is defined as a Markush group. A Markush group is a closed group of alternatives, i.e., the selection is made from a group “consisting of” (rather than “comprising” or “including”) the alternative members. If a Markush grouping requires a material selected from an open list of alternatives (e.g., selected from the group comprising” or the recited alternatives), the claim should generally be rejected under 35 U.S.C. 112(b) as indefinite because it is unclear what other alternatives are intended to be encompassed by the claim. If a claim is intended to encompass combinations or mixtures of the alternatives set forth in the Markush grouping, the claim may include qualifying language preceding the recited alternatives (such as “at least one member” selected from the group), or within the list of alternatives (such as “or mixtures thereof”). See MPEP 2173.05(h). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 12-16 and 19-21 are rejected under 35 U.S.C. 103 as being unpatentable over EP 47625 in view of GB 1476479, and further in view of US 2,919,473, as evidenced by Affatato (Ageing of Composites: Chapter 13: Aging of polyethylene composite implants in medical devices. 2008, pp. 357-374). EP ‘625 exemplifies irradiating pellets of polyethylene resin containing 2 wt% carbon black with gamma (γ) irradiation (p. 7, Example I), which is known in the art to crosslink polyethylene, as evidenced by Affatato (p. 366), which inherently results in a plurality of chemical crosslinks that covalently bond a given polyethylene chain to another polyethylene chain. EP ‘625 does not teach or suggest how to make the pellets of polyethylene containing carbon black, but does mention CA 1017496 regarding the preferred polyethylene for use (p. 3). GB 1476479 is part of the family of CA 1017496. GB ‘479 teaches that compositions of ethylene polymer and carbon black may be of significantly higher density than the density of the ethylene polymer in the composition (p. 3, ll. 20-28), which meets the claim limitation of the filler, carbon black, being property-modifying, as it modifies the density. GB ‘479 teaches that carbon black may be blended into ethylene polymers by known techniques, for example, a pellet blend of the ethylene polymer and a concentrate of polyethylene containing carbon black, may be fed to the mixing section of a compounding extruder (pp. 3-4). EP ‘625 requires the use of pellets of the polyethylene resin containing carbon black; therefore, compounding by way of an extruder followed by granulation (severing of an extrudate) to form pellets is inherently necessary, in view of the teachings of EP ‘625. EP ‘625 nor GB ‘479 teach the size of the pellets; however, EP ‘625 mentions US 2,919,473 in the background section for methods of known irradiation processes, where US ‘473 teaches that the polyethylene which is subjected to irradiation may be of any size or physical state, for example, in the finely divided state with an average particle size of 50-400 microns, or pellets of varying state, exemplified as ¼” to 3/8” (about 6-10 mm). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was filed to have used pellets having a size of 50 microns to 10 mm for irradiation and compounding in EP ‘625, as US ‘473 teaches that these sizes are suitable for gamma ray irradiation. EP ‘625 in view of GB ‘479 and US ‘473 is prima facie obvious over instant claims 12-16 and 19-20. As to claim 21, EP ‘625 teaches that the granules can be irradiation with electron irradiation (p. 4, ll. 14-20). Claims 17-18 are rejected under 35 U.S.C. 103 as being unpatentable over EP 47625 in view of GB 1476479 and US 2,919,473, as applied above to claims 12-16 and 19-21, and further in view of Guenther (US 2007/0232716). EP 47625 in view of GB 1476479 and US 2,919,473 is prima facie obvious over instant claims 1-16 and 1-21, as described above and applied herein as such, as EP ‘625 teaches irradiating pellets containing polyethylene and carbon black, where GB ‘479 teaches the method of making the pellets to be irradiated and US ‘473 teaches the size of pellets suitable for irradiation. EP ‘625 does not teach or suggest the inclusion of a crosslinking agent, as claimed. Guenther teaches that polyethylene resins produced with Ziegler-Natta catalysts can be modified through the use of cross-linking agents such as peroxides, to improve the polymer properties and increase efficiency of treatment with electron beams (p. 2, [0015]), particularly teaching that the use of peroxides to improve or increase the rheological breadth (p. 4, [0032]), where the peroxides are taught to include 2,5-dimethyl-2,5-di(t-butylperoxy)hexane (p. 2, [0019]). GB ‘479 teaches the method of preparing the polyethylene to include coordination catalysts, such as titanium tetrachloride and aluminum diethyl, also known in the art as Ziegler Natta catalysts (p. 3, ll. 57-99). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was filed to have incorporated a crosslinking agent with the carbon black and polyethylene pellet, prior to granulation and further irradiation, as Guenther teaches that the use of peroxide crosslinking and irradiation crosslinking results in a polymer with an improved rheological breadth. EP ‘625 in view of EP ‘479 and US ‘473, and further in view of Guenther is prima facie obvious over instant claims 17-18. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 3,130,139 teaches irradiating polyethylene pellets with ionizing radiation and subsequently admixing with carbon black. The instant invention requires mixing before irradiation. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIEANN R JOHNSTON whose telephone number is (571)270-7344. The examiner can normally be reached Monday-Friday, 8:00 AM - 4:00 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at (571)272-1302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Brieann R Johnston/Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Feb 07, 2024
Application Filed
Oct 29, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12799316
A POLYMER COMPOSITION COMPRISING PARTICLES AND COLORANT, ITS METHOD OF PREPARATION AND ITS USE
5y 7m to grant Granted Nov 17, 2026
Patent 12789448
BINDERS COMPRISING A MONOMER AND AN INITIATOR FOR USE IN ADDITIVE MANUFACTURING
4y 2m to grant Granted Nov 10, 2026
Patent 12774386
AN INJECTION MOLDING MATERIAL FOR PRODUCING MOLDED ARTICLES
3y 0m to grant Granted Oct 27, 2026
Patent 12753304
TRANSPARENT FLAME RETARDANT DUCTILE COMPOSITIONS AND THIN-WALL ARTICLES THEREOF
3y 4m to grant Granted Oct 06, 2026
Patent 12742057
BORON NITRIDE PARTICLES, RESIN COMPOSITION, AND METHOD FOR PRODUCING RESIN COMPOSITION
3y 7m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
82%
With Interview (+32.6%)
2y 10m (~1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1037 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month